Currently out of the existing stock ratings of Daniel Arias, 133 are a BUY (68.21%), 62 are a HOLD (31.79%).

Daniel Arias

Work Performance Price Targets & Ratings Chart

Analyst Daniel Arias, currently employed at STIFEL, carries an average stock price target met ratio of 58.85% that have a potential upside of 20.28% achieved within 152 days.

Daniel Arias’s has documented 391 price targets and ratings displayed on 27 stocks. The coverage is on Healthcare, Basic Materials sectors.

Most recent stock forecast was given on TXG, 10X Genomics at 13-Feb-2026.

Wall Street Analyst Daniel Arias

Analyst best performing recommendations are on TEM (TEMPUS AI, COMMON STOCK).
The best stock recommendation documented was for TEM (TEMPUS AI, COMMON STOCK) at 11/11/2024. The price target of $65 was fulfilled within 3 days with a profit of $12.62 (16.26%) receiving and performance score of 54.2.

Average potential price target upside

of $187.85 (16.93%) on MTD (METTLER-TOLEDO INTERNATIONAL).
of $83.21 (20.62%) on TMO (THERMO FISHER SCIENTIFIC).
of $46.01 (9.37%) on ILMN (ILLUMINA).

A Agilent Technologies AVTR Avantor BLI Berkeley Lights BRKR Bruker EXAS EXACT Sciences GH Guardant Health ILMN Illumina LMNX Luminex MASS 908 Devices MRVI Maravai Lifesciences Holdings RGEN Repligen RNLX Renalytix AI TECH Bio-Techne Corp TMO Thermo Fisher Scientific TXG 10X Genomics WAT Waters ABSI Absci Corp CDXS Codexis DHR Danaher PKI PerkinElmer MTD Mettler-Toledo International NSTG NanoString Technologies QGEN Qiagen NV SLGC Somalogic TX Ternium SA ADR MXCT MaxCyte TEM Tempus AI, Common Stock

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Vijay Kumar (EVERCORE)